It's a real eye-opener sometimes to watch these deals come around to the end of their respective lockup periods. Some of these names were, and still are, great companies. Others were simply well-timed IPOs. The distinction will be made clear as they pass through the lockup expirations. The stocks worth owning over the long term -- names such as
-- may get heavily bruised over the next few weeks, but in my eyes that just makes them cheaper, and therefore more attractive.
Should you run out and buy these on the next dip? Probably not: It looks to me like there's still a big slug of downside in some of these names. What alarms me is not so much the selling that is taking place, but rather the apparent total lack of buyers. Do you want to be the first to jump in and call the turnaround? Or, is it an altogether smarter play to wait until the blood starts to dry and then selectively pick up or add on positions in the names you believe in?
Lots of questions.
Let's take a look at this week's expirations:
Ben Holmes is the founder of
ipoPros.com , a Boulder, Colo.-based research boutique (now a wholly-owned subsidiary of TheStreet.com) specializing in the analysis of equity syndicate offerings. This column is not meant as investment advice; it is instead meant to provide insight into the methods of new and secondary offerings. Neither Holmes nor his firm has entered indications of interest in any of the companies discussed in this column. Holmes' This Week in IPOs column appears Sundays, This Week's Secondaries appears Tuesdays, Upcoming Lockup Expirations appears Wednesdays and The Quiet Period appears on Fridays. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Holmes appreciates your feedback at